- Home
- ONDS vs CRVO Comparison
ONDS vs CRVO Comparison
Compare ONDS & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONDS
- CRVO
- Stock Information
- Founded
- ONDS 2014
- CRVO 2001
- Country
- ONDS United States
- CRVO United States
- Employees
- ONDS N/A
- CRVO N/A
- Industry
- ONDS Telecommunications Equipment
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- ONDS Telecommunications
- CRVO Health Care
- Exchange
- ONDS Nasdaq
- CRVO Nasdaq
- Market Cap
- ONDS 108.4M
- CRVO 95.4M
- IPO Year
- ONDS N/A
- CRVO N/A
- Fundamental
- Price
- ONDS $1.11
- CRVO $13.58
- Analyst Decision
- ONDS Buy
- CRVO Strong Buy
- Analyst Count
- ONDS 1
- CRVO 8
- Target Price
- ONDS $4.00
- CRVO $25.43
- AVG Volume (30 Days)
- ONDS 13.3M
- CRVO 13.9M
- Earning Date
- ONDS 05-14-2025
- CRVO 05-13-2025
- Dividend Yield
- ONDS N/A
- CRVO N/A
- EPS Growth
- ONDS N/A
- CRVO N/A
- EPS
- ONDS N/A
- CRVO N/A
- Revenue
- ONDS $7,192,694.00
- CRVO $9,737,974.00
- Revenue This Year
- ONDS $257.28
- CRVO N/A
- Revenue Next Year
- ONDS $119.78
- CRVO N/A
- P/E Ratio
- ONDS N/A
- CRVO N/A
- Revenue Growth
- ONDS N/A
- CRVO 36.29
- 52 Week Low
- ONDS $0.54
- CRVO $1.80
- 52 Week High
- ONDS $3.40
- CRVO $25.92
- Technical
- Relative Strength Index (RSI)
- ONDS 55.91
- CRVO 70.67
- Support Level
- ONDS $0.72
- CRVO $8.64
- Resistance Level
- ONDS $1.25
- CRVO $10.72
- Average True Range (ATR)
- ONDS 0.13
- CRVO 2.51
- MACD
- ONDS 0.08
- CRVO 0.18
- Stochastic Oscillator
- ONDS 76.67
- CRVO 70.88
Stock Price Comparison Chart: ONDS vs CRVO
About ONDS Ondas Holdings Inc.
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.